文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

高氧与动脉瘤性蛛网膜下腔出血机械通气患者不良结局增加呈剂量依赖性相关:一项回顾性队列研究

Hyperoxia is Dose-Dependently Associated with an Increase of Unfavorable Outcomes in Ventilated Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cohort Study.
PubMed 文献 · Neurocrit Care · 2022-06-08
一句话结论动脉瘤性蛛网膜下腔出血机械通气患者中,paO2超过80、100、120、150 mm Hg的氧积分与30天死亡率剂量依赖性升高相关;时间加权平均paO2在78-85 mm Hg时结局最佳,高于93 mm Hg死亡率增加。

这项回顾性单中心队列研究纳入2010年11月至2021年2月共282例动脉瘤性蛛网膜下腔出血且机械通气>72小时的患者,计算入院至第1、3、14天超过80、100、120、150 mm Hg的氧积分及时间加权平均paO2,多因素logistic回归校正年龄、性别、通气时长和Hunt-Hess分级。第14天时,paO2每高于阈值1 mm Hg/天的30天死亡率OR分别为1.07(>80)、1.16(>100)、1.36(>120)、1.59(>150),均p<0.001;3个月良好结局OR分别为0.96、0.90、0.83、0.77,均p<0.05。时间加权平均paO2第二四分位(78-85 mm Hg)30天死亡率最低、3个月良好结局最高;高于93 mm Hg(第四四分位)30天死亡率OR 3.4(95%CI 1.4-8.4,p=0.007)。第1天、第3天、出院时良好结局及迟发性脑缺血均无显著关联。作者强调需在前瞻性临床研究中进一步明确SAH机械通气患者的氧合阈值。

要点

  • 第14天时,paO2每高于80 mm Hg 1 mm Hg/天的30天死亡率OR 1.07(95%CI 1.03-1.11,p=0.001),高于100、120、150 mm Hg的OR分别为1.16、1.36、1.59(均p<0.001)。
  • 3个月良好结局(GOS 4-5分)的OR随阈值升高而降低:>80 mm Hg为0.96(95%CI 0.92-0.99),>100为0.90(0.84-0.98),>120为0.83(0.72-0.97),>150为0.77(0.61-0.97),均p<0.05。
  • 时间加权平均paO2第二四分位(78-85 mm Hg)30天死亡率最低、3个月良好结局最高;高于93 mm Hg(第四四分位)30天死亡率OR 3.4(95%CI 1.4-8.4,p=0.007)。
  • 3个月良好结局OR在第一、第三、第四四分位分别为0.28(95%CI 0.12-0.69)、0.27(0.11-0.67)、0.24(0.10-0.59),均p<0.01,提示低于和高于某范围均与不良结局相关。
  • 第1天、第3天氧积分、出院时良好结局及迟发性脑缺血均无显著关联。

适用人群与场景

  • 动脉瘤性蛛网膜下腔出血且机械通气>72小时的患者,来自2010年11月至2021年2月单中心549例中的282例纳入分析。

诊断标准与关键阈值

  • 良好结局定义为格拉斯哥结局量表(GOS)评分4分和5分。
  • 氧积分阈值:paO2高于80、100、120、150 mm Hg;计算时段为入院至第1天结束、第3天、第14天。
  • 时间加权平均paO2按四分位分组,第二四分位为78-85 mm Hg,第四四分位为>93 mm Hg。

研究设计与关键结果

  • 回顾性单中心队列研究,282例动脉瘤性SAH机械通气>72小时患者,多因素logistic回归校正年龄、性别、通气时长和Hunt-Hess分级。
  • 第14天氧积分:30天死亡率OR随阈值升高呈剂量依赖性增加,每高于80 mm Hg 1 mm Hg/天OR 1.07(95%CI 1.03-1.11,p=0.001);高于100 mm Hg OR 1.16(95%CI 1.07-1.27);高于120 mm Hg OR 1.36(95%CI 1.15-1.61);高于150 mm Hg OR 1.59(95%CI 1.22-2.08),均p<0.001。
  • 第14天氧积分与3个月良好结局:每高于80 mm Hg 1 mm Hg/天OR 0.96(95%CI 0.92-0.99);高于100 mm Hg OR 0.90(95%CI 0.84-0.98);高于120 mm Hg OR 0.83(95%CI 0.72-0.97);高于150 mm Hg OR 0.77(95%CI 0.61-0.97),均p<0.05。
  • 时间加权平均paO2:第二四分位(78-85 mm Hg)30天死亡率最低、3个月良好结局最高;高于93 mm Hg(第四四分位)30天死亡率OR 3.4(95%CI 1.4-8.4,p=0.007)。
  • 3个月良好结局OR:第一四分位0.28(95%CI 0.12-0.69)、第三四分位0.27(95%CI 0.11-0.67)、第四四分位0.24(95%CI 0.10-0.59),均p<0.01。
  • 第1天和第3天氧积分、出院时良好结局及迟发性脑缺血均无显著关联。

证据类型、等级与局限

  • 证据类型:回顾性单中心队列研究。
  • 局限:原文报告为回顾性单中心研究;作者指出需在前瞻性临床研究中进一步明确SAH机械通气患者的氧合阈值。

对床旁实践的改变

  • 作者认为,paO2超过所定义阈值的氧积分与SAH机械通气患者死亡率增加呈剂量依赖性相关,不良结局在通常定义为正常氧合的paO2范围内即增加,强调需在前瞻性临床研究中进一步明确氧合阈值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Adequate oxygenation in patients with aneurysmal subarachnoid hemorrhage (SAH) is imperative. However, hyperoxia increases formation of reactive oxygen species and may be associated with a dose-dependent toxicity. We postulated a threshold for arterial partial pressure of oxygen (paO2) above which toxicity effects precipitate and sought to study the effects on 30-day mortality, favorable outcome at discharge and at 3 months, and delayed cerebral ischemia.

METHODS: In this retrospective single-center cohort study, patients with SAH and mechanical ventilation > 72 h were included. Oxygen integrals were calculated above the following thresholds: 80, 100, 120, and 150 mm Hg and time-weighted mean paO2. All calculations were done from admission to end of day 1, day 3, and day 14. We conducted multivariable logistic regression analyses adjusted for age, sex, duration of ventilation, and Hunt and Hess grade. Time-weighted mean paO2 was categorized by quartiles. Favorable outcome was defined as Glasgow Outcome Scale scores of 4 and 5.

RESULTS: From November 2010 to February 2021, 282 of 549 patients fulfilled the inclusion criteria. Odds ratios for 30-day mortality increased dose dependently and were as follows: 1.07 (95% confidence interval [CI] 1.03-1.11; p = 0.001) for each 1 mm Hg per day above 80 mm Hg; 1.16 (95% CI 1.07-1.27), above 100 mm Hg; 1.36 (95% CI 1.15-1.61), above 120 mm Hg; and 1.59 (95% CI 1.22-2.08), above 150 mm Hg (all p < 0.001) at day 14. For favorable outcome at 3 months, odds ratios were 0.96 (95% CI 0.92-0.99) for each 1 mm Hg per day above 80 mm Hg; 0.90 (95% CI 0.84-0.98), above 100 mm Hg; 0.83 (95% CI 0.72-0.97), above 120 mm Hg; and 0.77 (95% CI 0.61-0.97), above 150 mm Hg (all p < 0.05). For time-weighted mean paO2, lowest 30-day mortality and highest favorable outcome at 3 months were found in the second quartile (78-85 mm Hg). Thirty-day mortality increased above 93 mm Hg (fourth quartile), with an odds ratio of 3.4 (95% CI 1.4-8.4, p = 0.007). Odds ratios for favorable outcome at 3 months were 0.28 (95% CI 0.12-0.69), 0.27 (95% CI 0.11-0.67), and 0.24 (95% CI 0.10-0.59) for the first, third, and fourth quartiles, respectively (all p < 0.01). No significant association was found at day 1 and day 3, for favorable outcome at discharge, or for delayed cerebral ischemia.

CONCLUSIONS: Integrals above the defined paO2 thresholds were dose-dependently associated with an increase in mortality in ventilated patients with SAH. When we considered time-weighted mean paO2, unfavorable outcomes and 30-day mortality were more frequent both below and above a certain range. Unfavorable outcomes increased in paO2 ranges usually defined as normoxia. This emphasizes the necessity to further characterize oxygenation thresholds in ventilated patients with SAH in prospective clinical studies.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Grensemann J, Mader MM, Westphal M, et al. Hyperoxia is Dose-Dependently Associated with an Increase of Unfavorable Outcomes in Ventilated Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cohort Study. Neurocrit Care. 2022. PMID: 35672497. doi:10.1007/s12028-022-01534-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。